2198 — China Sanjiang Fine Chemicals Co Balance Sheet
0.000.00%
- HK$5.83bn
- HK$18.54bn
- CNY18.47bn
Annual balance sheet for China Sanjiang Fine Chemicals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 852 | 368 | 380 | 598 | 716 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 629 | 698 | 2,156 | 2,264 | 1,357 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,518 | 4,919 | 6,284 | 7,728 | 8,348 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 9,122 | 12,017 | 13,808 | 14,070 | 13,749 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 14,278 | 18,259 | 21,002 | 22,106 | 22,371 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7,539 | 10,609 | 12,420 | 13,694 | 15,224 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 9,612 | 13,961 | 16,621 | 17,194 | 17,058 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 4,666 | 4,298 | 4,381 | 4,912 | 5,313 |
| Total Liabilities & Shareholders' Equity | 14,278 | 18,259 | 21,002 | 22,106 | 22,371 |
| Total Common Shares Outstanding |